))
Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...
Manage episode 454955078 series 3623299
Dave Bjork द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Dave Bjork या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at Johnson & Johnson, where she is spearheading innovative cancer treatments and advocating for equity in healthcare.
She is committed to advancing the organization’s solid tumor portfolio and pipeline, spanning prostate, bladder, and lung cancer, as well as multiple novel treatment pathways. Biljana is passionately focused on bringing medical innovation and ultimately transforming patient care.
Biljana is a physician by training and graduated in 2001 from the Belgrade University Medical School. She worked as a practicing physician for several years before transitioning to industry. She also holds an executive education degree from the London Business School.
researchevangelist.com
एक एपिसोड
साझा करें
